StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories nutritional Products Segment Total — U.S. Revenue ($M) ($M)

Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A

Latest, FY2025
3,606
Period ended Dec 31, 2025
Change on a year earlier
-2.2%
3,689 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNutritional Products Segment Total — U.S. Revenue ($M) ($M)Year on yearSource
FY2025Dec 31, 20253,606-2.2%SEC Filing (0001628280-26-002982) ↗
FY2024Dec 31, 20243,689+8.1%SEC Filing (0001628280-25-002092) ↗
FY2023Dec 31, 20233,413+16.9%SEC Filing (0001628280-24-002009) ↗
FY2022Dec 31, 20222,919-17.9%SEC Filing (0001628280-23-001516) ↗
FY2021Dec 31, 20213,556+8.4%SEC Filing (0001104659-22-007648) ↗
FY2020Dec 31, 20203,279+5.4%SEC Filing (0001104659-21-007942) ↗
FY2019Dec 31, 20193,110+1.1%SEC Filing (0001104659-20-005717) ↗
FY2018Dec 31, 20183,075+1.5%SEC Filing (0001104659-19-002848) ↗
FY2017Dec 31, 20173,031+2.1%SEC Filing (0001104659-18-003691) ↗
FY2016Dec 31, 20162,969+3.5%SEC Filing (0001104659-17-003920) ↗
FY2015Dec 31, 20152,868–SEC Filing (0001104659-16-091861) ↗

Breakdown

What makes up nutritional products segment total — u.s. revenue ($m)

Cite this data

StockData. (2026). Abbott Laboratories Nutritional Products Segment Total — U.S. Revenue ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/nut-tot-rev-us

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.